Skip to main content

Table 3 Comparison of serum levels of sFas and sFasL in different subgroups of gastric adenocarcinoma with non-tumoral group

From: Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma

 

sFas (pg/ml)

sFasL (pg/ml)

 

N*

Mean ± SE.M†

P Value

N*

Mean ± SE.M†

P Value

Gastric Cancer Group

  

(vs. Non-Tumoral)

  

(vs. Non-Tumoral)

   Overall

56

305.97 ± 63.71

< 0.001

59

0.138 ± 0.04

< 0.001

   Intestinal

43

293.06 ± 73.88

< 0.001

45

0.147 ± 0.05

< 0.001

   Diffuse

13

348.61 ± 129.43

< 0.001

14

0.109 ± 0.05

< 0.001

   Cardia

18

242.72 ± 62.78

0.001

18

0.026 ± 0.01

< 0.001

   Non-cardia

37

358.92 ± 99.61

< 0.001

40

0.206 ± 0.07

< 0.001

Non-Tumoral Group

59

92.98 ± 4.95

 

62

0.150 ± 0.02

 
  1. * N: Number of samples
  2. † Mean ± SE.M: Mean Serum Range ± Standard Error of Mean
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us